Business Of Biotech

241 Episodes

1. Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management

   Published: 6/13/2022
2. The Biotech Beatdown With Allan Shaw

   Published: 6/6/2022
3. Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO

   Published: 5/30/2022
4. What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

   Published: 5/23/2022
5. Running Interference: RNAi with Silence Therapeutics' Craig Tooman

   Published: 5/16/2022
6. Live Biologics & The Microbiome With 4D pharma's Duncan Peyton

   Published: 5/9/2022
7. Gene Tx For Renal Disease With Purespring CEO Richard Francis

   Published: 5/2/2022
8. Fighting Blindness & Funding The Fight With Opus Genetics' CEO Ben Yerxa, Ph.D.

   Published: 4/25/2022
9. Gynecological Cancer Therapies with Context Therapeutics' Martin Lehr

   Published: 4/18/2022
10. Commensal Viral Vectors with Ring Therapeutics' Tuyen Ong, M.D.

    Published: 4/11/2022
11. Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.

    Published: 4/4/2022
12. Gene Therapies For Ocular Disease With Sparing Vision's Stéphane Boissel

    Published: 3/28/2022
13. Biotech M&A Trends With Allan Shaw

    Published: 3/21/2022
14. Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.

    Published: 3/14/2022
15. CAR T-cells For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.

    Published: 3/7/2022
16. AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

    Published: 2/28/2022
17. Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago

    Published: 2/21/2022
18. Plant-Based Biologics With iBio's Randy Maddux

    Published: 2/14/2022
19. NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos

    Published: 2/7/2022
20. A Hybrid mAb Manufacturing Model With John Glasspool

    Published: 1/31/2022